IP Verse

Biotest competitive analysis

Loading summary...

Explore patent oppositions filed by Biotest against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3506915	Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders	PLAS FREE	Dec 5, 2024
EP3481415	Stable Liquid Fibrinogen	LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES	Jun 5, 2024
EP2945962	Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material	PROTHERA BIOLOGICS	Jan 17, 2020
EP2670429	Method For Inactivation/Removal Of Coagulation Factors By Precipitation	OCTAPHARMA	Dec 21, 2018
EP2825555	Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby	OCTAPHARMA	Apr 12, 2018

Explore the latest publications and patents granted to Biotest, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Biotest, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Biotest with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BIOTEST	5	-	-	-
LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES	-	10	-	-
OCTAPHARMA	7	8	-	-
PLAS FREE	-	2	-	-